Elliott Fegelman, MD, on Project Game Changer: The Role of Research
08/30/2017
Dr Elliott Fegelman, therapeutic area lead for Metabolics at Johnson & Johnson Innovation, discusses the role of research for the future of bariatric surgery and what lies ahead for Project Game Changer.
For more information on bariatric surgery, visit our Medical Resource Center.